Animal models for analyzing metabolic syndrome-associated liver diseases

A diet-induced Sprague–Dawley rat model of nonalcoholic steatohepatitis-related cirrhosis

(2017) Mayuko Ichimura et al.   JOURNAL OF NUTRITIONAL BIOCHEMISTRY

The epidemiology of non-alcoholic fatty liver disease

(2017) Stefano Bellentani   LIVER INTERNATIONAL

Daily Coffee Intake Inhibits Pancreatic Beta Cell Damage and Nonalcoholic Steatohepatitis in a Mouse Model of Spontaneous Metabolic Syndrome, Tsumura-Suzuki Obese Diabetic Mice

(2017) Syunsuke Watanabe et al.   Metabolic Syndrome and Related Disorders

Non-alcoholic fatty liver disease: A sign of systemic disease

(2017) Isabella Reccia et al.   METABOLISM-CLINICAL AND EXPERIMENTAL

Fructo-oligosaccharides and intestinal barrier function in a methionine–choline-deficient mouse model of nonalcoholic steatohepatitis

(2017) Kotaro Matsumoto et al.   PLoS One

Morphophenotypic changes in human multistep hepatocarcinogenesis with translational implications

(2016) Amedeo Sciarra et al.   JOURNAL OF HEPATOLOGY

Aberrant iron metabolism might have an impact on progression of diseases in Tsumura Suzuki obese diabetes mice, a model of spontaneous metabolic syndrome

(2016) Takeshi Nishida et al.   PATHOLOGY INTERNATIONAL

An Overview of NAFLD/NASH in Japan

(2016) Soo Ryang Kim et al.   YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN

High fat diet drives obesity regardless the composition of gut microbiota in mice

(2016) Sylvie Rabot et al.   Scientific Reports

Evidence-based clinical practice guidelines for nonalcoholic fatty liver disease/nonalcoholic steatohepatitis

(2015) Sumio Watanabe et al.   JOURNAL OF GASTROENTEROLOGY

Current efforts and trends in the treatment of NASH

(2015) Vlad Ratziu et al.   JOURNAL OF HEPATOLOGY

Neonatal streptozotocin treatment causes type 1 diabetes and subsequent hepatocellular carcinoma in DIAR mice fed a normal diet

(2014) Hayato Baba et al.   Hepatology International

High-fat and high-cholesterol diet rapidly induces non-alcoholic steatohepatitis with advanced fibrosis in Sprague-Dawley rats

(2014) Mayuko Ichimura et al.   HEPATOLOGY RESEARCH

Neonatal monosodium glutamate treatment causes obesity, diabetes, and macrovesicular steatohepatitis with liver nodules in DIAR mice

(2014) Koichi Tsuneyama et al.   JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY

A Dietary Restriction Influences the Progression But Not the Initiation of MSG-Induced Nonalcoholic Steatohepatitis

(2014) Makoto Fujimoto et al.   JOURNAL OF MEDICINAL FOOD

Gd-EOB-DTPA-Enhanced MRI is Better than MDCT in Decision Making of Curative Treatment for Hepatocellular Carcinoma

(2013) Sun Hong Yoo et al.   ANNALS OF SURGICAL ONCOLOGY

Non-B, non-C hepatocellular carcinoma

(2013) HIROKI NISHIKAWA et al.   INTERNATIONAL JOURNAL OF ONCOLOGY

Hepatocellular carcinoma in patients with chronic hepatitis C virus infection in the Asia–Pacific region

(2013) Mi Na Kim et al.   JOURNAL OF GASTROENTEROLOGY

Characteristics and diagnosis of NAFLD/NASH

(2013) Etsuko Hashimoto et al.   JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY

A murine model for non-alcoholic steatohepatitis showing evidence of association between diabetes and hepatocellular carcinoma

(2013) Masato Fujii et al.   Medical Molecular Morphology

Spirulina improves non-alcoholic steatohepatitis, visceral fat macrophage aggregation, and serum leptin in a mouse model of metabolic syndrome

(2012) Makoto Fujimoto et al.   DIGESTIVE AND LIVER DISEASE

Study of the Effects of Monacolin K and Other Constituents of Red Yeast Rice on Obesity, Insulin-Resistance, Hyperlipidemia, and Nonalcoholic Steatohepatitis Using a Mouse Model of Metabolic Syndrome

(2012) Makoto Fujimoto et al.   Evidence-based Complementary and Alternative Medicine

Bile salt export pump is dysregulated with altered farnesoid X receptor isoform expression in patients with hepatocellular carcinoma

(2012) Yuan Chen et al.   HEPATOLOGY

Spontaneous onset of nonalcoholic steatohepatitis and hepatocellular carcinoma in a mouse model of metabolic syndrome

(2012) Takeshi Nishida et al.   LABORATORY INVESTIGATION

Animal models of nonalcoholic fatty liver disease/nonalcoholic steatohepatitis

(2012) Yoshihisa Takahashi   WORLD JOURNAL OF GASTROENTEROLOGY

Animal models for the study of hepatic fibrosis

(2011) Peter Starkel et al.   BEST PRACTICE & RESEARCH IN CLINICAL GASTROENTEROLOGY

Effects of bezafibrate in nonalcoholic steatohepatitis model mice with monosodium glutamate-induced metabolic syndrome

(2011) Yoshiyuki Sasaki et al.   EUROPEAN JOURNAL OF PHARMACOLOGY

Treatment with SRT1720, a SIRT1 activator, ameliorates fatty liver with reduced expression of lipogenic enzymes in MSG mice

(2009) Yu Yamazaki et al.   AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM

Dose dependent development of diabetes mellitus and non-alcoholic steatohepatitis in monosodium glutamate-induced obese mice

(2009) Yoshiyuki Sasaki et al.   LIFE SCIENCES

Monosodium glutamate (MSG): A villain and promoter of liver inflammation and dysplasia

(2008) Yuko Nakanishi et al.   JOURNAL OF AUTOIMMUNITY